pharmaphorum

Isomorphic raises $1.2bn for AI drug hunt

Isomorphic Labs' chief executive, Sir Demis Hassabis, delivering his Nobel Prize lecture in 2024. Alphabet-backed start-up Isomorphic Labs has added to the lustre attached to its AI-powered drug ...
CNBC

Isomorphic Labs President: Working hard to create new wave of medicine

Monday - Friday, 08:00 - 11:00 CET | 14:00 - 17:00 HK/SG Max Jaderberg, President of Isomorphic Labs, speaks to CNBC's Ritika Gupta at London Tech Week to discuss the advancement of AI in medicine Got ...
Yahoo Finance

Demis Hassabis on his rush to ‘solve all disease’ and Isomorphic’s new $2.1 billion

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
MobiHealthNews

Google-backed Isomorphic Labs raises $2.1B for AI drug discovery platform

Isomorphic Labs, an AI drug discovery and development company, raised $2.1 billion in a Series B funding round led by Thrive Capital. The raise was also backed by existing investors Alphabet and GV ...
Forbes

Isomorphic Labs’ $2.1 Billion Fundraise Is The Biggest Bet Yet On AI Drug Discovery

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Demis Hassabis, CEO of Isomorphic and Google DeepMind Isomorphic, which formed as an ...
cio.economictimes.indiatimes

Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery

Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion in its latest funding round led by existing investor Thrive Capital. The funding ...
SiliconRepublic

Alphabet’s Isomorphic Labs raises $2.1bn in Series B funding

The organisation plans to use the investment as a means of accelerating the application of its AI model at scale. AI-powered drug design and development company Isomorphic Labs has announced a raise ...
PR Newswire

Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine

Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline. LONDON, May 12, 2026 /PRNewswire/ -- ...
Bloomberg L.P.

DeepMind Spinout Isomorphic Labs Raises $2.1 Billion to Design Drugs With AI

Alphabet Inc.’s Isomorphic Labs raised $2.1 billion in its second round of outside capital, with new support from sovereign wealth funds, as it seeks to make artificial intelligence-designed drugs a ...
FierceBiotech

Alphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model

Ruth Porat, President and Chief Investment Officer of Alphabet and Google, said Isomorphic has “already made extraordinary progress in harnessing AI to accelerate drug discovery.” (iStock/Getty Images ...
U.S. News & World Report

Google-Backed Isomorphic Raises $2.1 Billion to Scale AI-Driven Drug Discovery

May 12 (Reuters) - Isomorphic Labs, an artificial ⁠intelligence-driven ⁠drug discovery company, said ⁠on Wednesday it has raised $2.1 billion in its latest funding round led by existing investor ...
Morningstar

Alphabet-Backed Isomorphic Labs Raises $2.1 Billion for AI Drug Development

Isomorphic Labs raised $2.1 billion in its Series B funding round to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas. The subsidiary of Google parent Alphabet ...